Complete Clinical, Histopathologic and Molecular Remission of Primary Myelofibrosis with Long-Term Treatment with the JAK1/2 Inhibitor Ruxolitinib

Autor: Al-Ali, Haifa Kathrin *, Hubert, Karolin *, Lange, Thoralf *, Siebolts, Udo *, Wichenhauser, Claudia *, Prashanth, Gopalakrishna *, Niederwieser, Dietger, Monecke, Astrid *
Zdroj: In Blood 6 December 2014 124(21):1836-1836
Databáze: ScienceDirect